The Alliance for Benzodiazepine Best Practices, a national non-profit, is recruiting for our voluntary Board of Directors positions. Board members bring their experience and commitment to improving the lives of millions who are prescribed benzodiazepines (such as Xanax, Valium, Klonopin and Ativan) through changes in awareness, clinical practice and health systems improvement.
In 4 years, the Alliance has published the most thorough book on benzodiazepine harm, The Benzodiazepines Crisis, and has published eight peer-reviewed papers building the evidence base for problem benzodiazepine prescribing. We have given over 40 education courses for prescribers in many different venues. Working with the University of Arizona, we have conducted a symposium on BZDs and have a study underway exploring how these drugs harm the body. We have 4 more papers being written, plus three study proposals being evaluated – one at the request of the FDA.
We are seeking new board members for a two-year term, in particular, with:
- Financial expertise
- Fund-raising experience
- Marketing, Outreach, and Public Relations background
- Non-profit board service
Board responsibilities include:
- Attending quarterly board meetings via Zoom
- Advancing Alliance growth and development using each board member’s passion and expertise
- Inform Alliance strategic planning and resource allocation
- Promoting Alliance objectives through changes in clinical practice
- Promoting Alliance objectives through improvements in public health outcomes
Please share with any contacts or connections who may be interested.
Contact Dr. Doryn Davis Chervin at doryn.chervin@gmail.com
The Alliance’s mission is to significantly reduce the number of benzodiazepine withdrawal sufferers by reducing the number of new prescriptions for benzodiazepines and Z-drugs, limit the duration of use, and provide an evidence-based pathway for deprescribing.
